Search

everythinglearnresearchcommunity

for

Search:↓

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Bald men with male pattern baldness still have hair stem cells, but lack certain cells needed to grow hair.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Stem cell behavior varies with stimuli, and lineage changes can happen without affecting stem cell division.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Researchers identified potential markers for human hair color stem cells.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Hair follicle cells resist turning into skin cells.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Immune cells affect hair growth and could lead to new hair loss treatments.

Injecting a cell suspension from hair follicles increased hair density in a balding patient.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

The method successfully isolates hair follicle stem cells from mice for research.

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

TLR7-based compounds may help manage chemotherapy-induced hair loss.